# clm_F408F42211E9

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: quarterly_research_and_development  
value: 767,000,000 United States dollar  
valid_from: 2026-03-31  
valid_to: 2026-06-30  
published: 2026-04-29  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_A04DCE763037  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories quarterly research and development: 767,000,000 United States dollar", as of 2026-03-31 (until 2026-06-30). Claim clm_F408F42211E9, https://asof.is/claim/clm_F408F42211E9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/0001628280-26-028357-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2026, filed 2026-04-29  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/0001628280-26-028357-index.htm (primary, SEC EDGAR 10-Q Q1 FY2026, published 2026-04-29)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | quarterly_research_and_development | 766,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_F408F42211E9](/claim/clm_F408F42211E9.md) | [clm_1266BBB313EF](/claim/clm_1266BBB313EF.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.